New meta-analysis finds oral anticoagulants reduce net adverse events in patients with atrial fibrillation after intracranial hemorrhage but with a higher risk for recurrent intracranial hemorrhage.

Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector. Guggenheim ...